Jan 11 2012
uVera Diagnostics has introduced the CR3 Keyless Split Sample Cup to its inventory. The new drug screening specimen cup provides several state-of-the-art features not available together in any other product on the market.
"This is revolutionary to the drug testing industry," said Rick Nee, president of uVera Diagnostics. "The unisex cup opening is designed for ease of use for both genders. The unique patented device is keyless, further eliminating some of the challenges involved for clients in a drug testing situation."
Most urine drug screen test sample collection cups are designed with the testing process in mind. The CR3 not only ensures the testing process, but also the collection process. This specimen cup opens at an angle with a snap-secure lid. It has a non-reversible sample split device at the bottom, which preserves the rest of the sample for additional testing, if necessary.
"This is a cost-effective alternative for employers who want to conduct their own drug screenings," said Nee. "With 99 percent accuracy, it is also an affordable at-home drug test for parents to use on their children if they suspect a problem."
The device is FDA cleared and CLIA waived. It provides results within five minutes for panels of five to 14 specific drugs, including marijuana, cocaine, amphetamines, methamphetamine and opiates, while monitoring the sample's temperature to detect tampering.
The CR3 is now available for online purchase at uveradiagnostics.com.
U.S. cancer detection severely disrupted during first year of COVID-19, shows incomplete recovery in second year